J M Miller1, C Goodridge. 1. Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, New Orleans 70112-2822, USA.
Abstract
OBJECTIVE: This study evaluated the relationship between marijuana use and sexually transmitted diseases in pregnant women. METHODS: A retrospective review of clinic records over a 12-1/2 month period identified all women entering prenatal care. Eighty-six women using no illicit substance other than marijuana were compared to 441 drug-free women. The prevalence of gonorrhea, chlamydia, syphilis, human immunodeficiency virus, hepatitis B surface antigen, human papilloma virus, and herpes was ascertained. RESULTS: No significant differences were found in the prevalence of any single sexually transmitted disease between pregnant women who used marijuana and drug-free pregnant women. When the presence of one or more sexually transmitted disease was considered, again no difference was found. CONCLUSION: Marijuana use was not associated with sexually transmitted disease in pregnant women.
OBJECTIVE: This study evaluated the relationship between marijuana use and sexually transmitted diseases in pregnant women. METHODS: A retrospective review of clinic records over a 12-1/2 month period identified all women entering prenatal care. Eighty-six women using no illicit substance other than marijuana were compared to 441 drug-free women. The prevalence of gonorrhea, chlamydia, syphilis, human immunodeficiency virus, hepatitis B surface antigen, human papilloma virus, and herpes was ascertained. RESULTS: No significant differences were found in the prevalence of any single sexually transmitted disease between pregnant women who used marijuana and drug-free pregnant women. When the presence of one or more sexually transmitted disease was considered, again no difference was found. CONCLUSION:Marijuana use was not associated with sexually transmitted disease in pregnant women.
Authors: N Day; U Sambamoorthi; P Taylor; G Richardson; N Robles; Y Jhon; M Scher; D Stoffer; M Cornelius; D Jasperse Journal: Neurotoxicol Teratol Date: 1991 May-Jun Impact factor: 3.763
Authors: B Zuckerman; D A Frank; R Hingson; H Amaro; S M Levenson; H Kayne; S Parker; R Vinci; K Aboagye; L E Fried Journal: N Engl J Med Date: 1989-03-23 Impact factor: 91.245
Authors: P H Shiono; M A Klebanoff; R P Nugent; M F Cotch; D G Wilkins; D E Rollins; J C Carey; R E Behrman Journal: Am J Obstet Gynecol Date: 1995-01 Impact factor: 8.661